secwatch.observer — SEC 8-K summary
======================================

Issuer:     Marker Therapeutics, Inc. (MRKR)
CIK:        0001094038
Form:       8-K
Filed at:   2021-11-15T23:59:59+00:00
Accession:  0001104659-21-138506
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Marker Therapeutics appoints Juan Vera as CSO and COO effective Nov 12, 2021
----------------------------------------------------------------------------

- Juan Vera, former Chief Development Officer, appointed as Chief Scientific Officer and Chief Operating Officer.
- Effective November 12, 2021; he continues as a board member through the 2022 annual meeting.
- No family relationships or material interests in transactions require disclosure under Item 404(a).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1094038/000110465921138506/0001104659-21-138506-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1094038/000110465921138506/tm2132865d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-138506

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer